We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Thermo Fisher Scientific - Direct Effect Media

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Robotic Surgery System with Single-Use Instrument Concept Eliminates Cross-Contamination Risk

By HospiMedica International staff writers
Posted on 11 May 2022
Print article
Image: avatera robot-assisted surgery system has progressed to clinical use (Photo courtesy of avateramedical GmbH)
Image: avatera robot-assisted surgery system has progressed to clinical use (Photo courtesy of avateramedical GmbH)

Up to now the use of robot-assisted procedures has been extremely resource intensive and therefore, not a viable option for many clinics. Now, a new robot-assisted, minimally invasive surgical system based on a unique and consistent single-use concept reduces the associated risk of contamination and at the same time avoids the costs of cleaning and sterilizing the instruments.

avateramedical GmbH’s (Jena, Germany) avatera is the first German system for robot-assisted, minimally invasive surgery and was developed as a high-quality solution for minimally invasive robotic surgery. Tailored to address specific user needs, the cutting-edge system enables precise keyhole surgery (so-called laparoscopy) with the highest level of safety for patients and maximum ergonomic comfort for surgeons and surgical teams. Its single-use concept for surgical instruments eliminates the need for complex and expensive sterilization processes, saving costs while always providing surgeons with new, reliable instruments, removing the risk of cross-contamination.

Additionally, the avatera system builds on and improves the features and functionality of currently available surgical robots, is easy and comfortable to use, and is specifically tailored to the needs of surgeons and their teams. The built-in seat and individual ergonomic adjustment options allow surgeons to work comfortably even during very long operations. An open design and low noise levels allow for ease of communication for the surgical teams. The compact system does not require much space and can easily fit in a wide variety of operating rooms.

The avatera robot-assisted, minimally invasive surgery system has successfully completed the first 10 surgeries in humans and has now been introduced into everyday clinical practice at the first hospital worldwide, the University of Leipzig Medical Center. Additionally, avatera has received the CE mark and is approved for minimally invasive surgery in urology and gynecology in the European Economic Area. Currently, the system is being rolled out at partner sites which will allow the company to gain additional experience in clinical routines.

“With the first in-human surgeries, we are entering a new exciting chapter in our company’s history,” said Greg Roche, CEO of avateramedical N.V. “It is our vision to make cutting-edge, efficient robot-assisted surgery accessible for every patient around the world.”

“The first surgical procedures on patients were performed at the University of Leipzig Medical Center to remove prostate and kidney tumors. We are thrilled that these procedures were so successful and that surgeons and their patients are now beginning to benefit from our work,” added Andreas Wegner-Berndt, Managing Director of avateramedical GmbH.”

Related Links:
avateramedical GmbH 

Print article


Critical Care

view channel
Image: EsoGuard has demonstrated over 90% specificity and 90% sensitivity in identifying Barrett’s Esophagus (Photo courtesy of Lucid Diagnostics)

Biomarker Based Non-Endoscopic Technology Identifies Risk for Esophageal Cancer

Barrett's esophagus (BE) is the benign and treatable precursor condition to esophageal adenocarcinomas (EAC) which is usually diagnosed at an advanced stage and is difficult to treat. Finding BE, a sign... Read more

Patient Care

view channel
Image: Future wearable health tech could measure gases released from skin (Photo courtesy of Pexels)

Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases

Most research on measuring human biomarkers, which are measures of a body’s health, rely on electrical signals to sense the chemicals excreted in sweat. But sensors that rely on perspiration often require... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.